Select Medical
SEM was delisted on the 30th of June, 2026.
216 hedge funds and large institutions have $2.23B invested in Select Medical in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 68 increasing their positions, 93 reducing their positions, and 25 closing their positions.
6.84% more ownership
Funds ownership: 142.14% → 148.98% (+6.8%)
8% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 25
0% less funds holding
Funds holding: 217 → 216 (-1)
5% less capital invested
Capital invested by funds: $2.36B → $2.23B (-$127M)
27% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 93
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
96% less call options, than puts
Call options by funds: $15K | Put options by funds: $428K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$33.3M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$21.1M |
| 3 |
Bank of New York Mellon
New York
|
+$17.8M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$3.24M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$2.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$94M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$29.9M |
| 3 |
BlackRock
New York
|
-$22.4M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$11.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10M |
SEM Hedge Fund Activity: Q3 2022 in Review
216 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2022, worth a combined $2.23B — down 5.4% from $2.36B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new SEM positions and 25 closed out — a net gain of 2 holders — while 68 added to existing stakes and 93 trimmed.
The largest buyer was Invesco, adding an estimated $33.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $94M.
- 216 institutional investors held Select Medical (SEM) as of Q3 2022, down from 217 in Q2 2022.
- Funds reported $2.23B of Select Medical stock for Q3 2022, down 5.4% quarter-over-quarter.
- 27 funds opened new Select Medical positions in Q3 2022 and 25 closed out, a net change of +2 holders.
- The largest Select Medical buyer in Q3 2022 was Invesco, an estimated $33.3M added.
- The largest Select Medical seller in Q3 2022 was T. Rowe Price Associates, an estimated $94M sold.
Based on aggregated 13F filings for Q3 2022.